Tenax Therapeutics
Tenax Therapeutics maintains an oxygen supply to stop disease and damage to tissues that occurs when the flow of oxygen is interrupted.
Launch date
Employees
Market cap
€11.4m
Enterprise valuation
€3m (Public information from Sep 2024)
Share price
$3.62 TENX
Morrisville North Carolina (HQ)
Authorizing premium user...